Press release
CD BioGlyco Launches GalNAc-L96 Platform for Targeted siRNA Delivery to Hepatocytes

Official CD BioGlyco logo - A biotech pioneer specializing in targeted siRNA/mRNA delivery systems, featuring the proprietary GalNAc-L96 platform
CD BioGlyco has rolled out a newly designed nucleic acid drug delivery [https://www.bioglyco.com/nucleic-acid-drug-delivery-products.html] system for siRNA- and mRNA-based therapeutics.
Built around refined glycosylation chemistry, the platform focuses on improving how molecules like siRNA and mRNA are brought into target cells. Rather than tweaking existing methods, the company has opted for a ground-up redesign that reflects recent lab needs-especially in gene-targeted treatments and RNA-based vaccines. In many labs, researchers working with nucleic acid drugs face the same challenges: the molecules degrade too easily, fail to efficiently reach target cells, or exhibit inconsistent performance across tissues. These limitations hinder research progress. CD BioGlyco's new system overcomes these issues by incorporating GalNAc sugar ligands for liver-specific targeting, enabling precise control over drug assembly and release.
The new platform is built around GalNAc-L96 [https://www.bioglyco.com/nucleic-acid-drug-delivery-products.html], CD BioGlyco's proprietary triantennary ligand designed to enhance liver-targeted siRNA delivery. This structure specifically binds the ASGPR receptor on hepatocytes, enabling efficient and selective cellular uptake. By leveraging GalNAc-L96, researchers can achieve modular assembly of oligonucleotide [https://www.bioglyco.com/oligonucleotide-modification-service.html] therapies, allowing for greater flexibility in optimizing drug performance and reducing off-target effects.
While the platform was built with liver-targeted treatments in mind, its modular design means it can be adapted for other uses too. Teams working in cancer biology, infectious disease, and metabolic disorders can use the same core chemistry to deliver payloads into different types of cells. In preclinical collaborations, the system has already shown better uptake and more even response across sample groups-especially in studies involving mRNA vaccines and gene silencing tools. "This wasn't about adding a feature or two," said Anna, a spokesperson for CD Bioglyco. "We kept seeing the same problems show up in nucleic acid drug delivery-especially when researchers moved from cell culture to animal models. So we stepped back and rebuilt the process. What we've got now is something that actually fits the pace and complexity of current RNA-based research." The company is currently working with several academic and biotech groups to refine its system across more cell types and disease areas. For labs looking to test nucleic acid therapies with tighter control and cleaner readouts, CD BioGlyco's new platform is now available for collaboration and pilot projects.
More information about the system and its development pipeline can be found at: https://www.bioglyco.com/nucleic-acid-drug-delivery-products.html
Media Contact
Company Name: CD BioGlyco
Contact Person: Anna Bryan
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=cd-bioglyco-launches-galnacl96-platform-for-targeted-sirna-delivery-to-hepatocytes]
Country: United States
Website: https://www.bioglyco.com/nucleic-acid-drug-delivery-products.html
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release CD BioGlyco Launches GalNAc-L96 Platform for Targeted siRNA Delivery to Hepatocytes here
News-ID: 4128576 • Views: …
More Releases from ABNewswire

MD Trim Clinic Expands Access to Breakthrough Weight Management Treatments in Du …
Image: https://www.abnewswire.com/upload/2025/09/f42141fdc32ce6b9d5700c221e9a21ce.jpg
Dr. Brandon Shaw, D.O., leads physician-guided program combining GLP-1/GIP medications, lifestyle support, and telemedicine for lasting results.
Dublin Clinic Brings Modern Medical Weight Loss to the Bay Area
MD Trim Clinic, a physician-led medical weight loss practice, has announced the opening of its Dublin, California office at 4101 Dublin Blvd, Suite F. Led by co-owner and medical director Dr. Brandon Shaw, D.O., the clinic specializes in FDA-approved GLP-1 and GIP therapies,…

Botpool Launches to Connect Companies Looking for AI Models & Solutions with Ver …
Botpool is a modern-age AI-focused platform that is emerging as the preferred destination for businesses seeking AI talent.
Image: https://www.abnewswire.com/upload/2025/09/e2583ace49552cb42382c21e6b56d61a.jpg
Botpool.ai [https://www.botpool.ai/] a next-generation freelance marketplace tailored specifically for AI professionals, has been launched with the goal to connect businesses with verified AI experts. Businesses can now use Botpool to easily hire AI talent to build automation, train models for machine learning, and integrate AI tools into their apps and workflows.
Speaking to…

Super Daddy Universe Launches: A New Era of Father-Child Bonding Through Play, C …
Super Daddy Universe has officially launched, redefining what it means to spend quality time between dads and their children. With the motto "Building Memories, One Brick at a Time," the brand is more than just an online store - it's a movement to celebrate the irreplaceable bond between fathers and their kids through play, imagination, and storytelling.
September 19, 2025 - Super Daddy Universe has officially launched, redefining what it means…

Advanced Marketing Automation Report: AI Integration, Answer Engine Optimization …
Marketing technology specialist Tony Hayes publishes in-depth analysis of 11 advanced digital marketing methodologies, featuring AI-powered automation systems, Answer Engine Optimization techniques, and sophisticated multi-platform revenue generation strategies currently being deployed by industry leaders.
Advanced Marketing Technology Report Reveals AI Integration and Automation Strategies Transforming Digital Revenue Generation
Marketing technology analyst Tony Hayes has released a comprehensive technical analysis examining 11 sophisticated digital marketing methodologies currently being implemented by advanced practitioners. The…
More Releases for BioGlyco
Glycosphingolipid Market Top Companies Study - CD BioGlyco, CarboCode Germany Gm …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Glycosphingolipid Market- (By Type (Neutral and Negatively Charged), By Application (Medical, Chemical and Others)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Glycosphingolipid Market is expected to expand with a CAGR of 4.68% during the forecast period of 2024-2031.
Get Free Access to Demo…
Empowering Growth: Glycomics Profiling Services Market 2024 and Industry Segment …
A new Report by Worldwide Market Reports, titled "Glycomics Profiling Services Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031," offers a comprehensive analysis of the industry, which comprises insights on the Glycomics Profiling Services market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
This report has a complete table of contents, figures, tables, and charts, as well as insightful analysis. The Glycomics…
Factors Influencing Global Complex Carbohydrate Profiling Services Market throug …
The worldwide "Complex Carbohydrate Profiling Services Market" 2023 Research Report presents a professional and complete analysis of the Global Complex Carbohydrate Profiling Services Market in the current situation. This report includes development plans and policies along with Complex Carbohydrate Profiling Services manufacturing processes and price structures. the reports 2023 research report offers an analytical view of the industry by studying different factors like Complex Carbohydrate Profiling Services Market growth, consumption…
Complex Carbohydrate Insights: Glycan Profiling Services Shaping Research | Chem …
Glycan Profiling Services Market 2023 Forecast: Unveiling Opportunities and Growth
Glycan Profiling Services market report presents an overview of the market on the basis of key parameters such as market size, revenue, sales analysis and key drivers. The market size of global Glycan Profiling Services market is anticipated to grow at large scale over the forecast period (2023-2029). The main purpose of the study report is to give users an extensive…
Top Key Players and Factors Driving Glycan Profiling Services Market Growth for …
Glycan Profiling Services Market Report Study
WMR has announced the addition of Glycan Profiling Services Market 2023 Forecast Analysis by Types, Applications, Size, Share, Key Players, and Regions. a new research report to its market research archive. The Glycan Profiling Services Market has been thoroughly researched and analysed by industry experts and researchers. The industry is examined at the global, regional, and national levels. The report highlights the primary revenue stream…
CD BioGlyco Introduces Custom Glycosylation Services of Proteins
CD BioGlyco, a leader in the field of glycan remodeling, released custom glycosylation services of proteins for its global customers based on biochemistry and organic chemistry.
Glycosylation is the process of adding glycans to proteins or lipids under the control of enzymes and occurs in the endoplasmic reticulum and Golgi apparatus. It transfers glycans to proteins under the action of glycosyltransferases and covalently binds to amino acid residues on proteins. Proteins…